↓ Skip to main content

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsGEN1046, a Bispecific Antibody…

Overview of attention for article published in Cancer Discovery, February 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
57 X users
patent
4 patents

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
67 Mendeley